Rivaroxaban (Xarelto)

rivaroxaban · Bayer and Janssen Pharmaceuticals (Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Rivaroxaban (Xarelto), covering 2012-01-12 to 2025-12-26. Get the full timeline:

Most recent: Clinical Trial Update: Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies [NA]

See pricing